InsidersTradesSigma
Track the ZyVersa Therapeutics, Inc. share price and the full directors' dealings record of the company, a listed equity based in United States. Shares are listed on the US market, under the oversight of SEC (Form 4). Market capitalisation: €955k. The latest transaction was disclosed on 20 December 2022 (Attribution). Among the most active insiders: Wolfe Peter. Every trade is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
6 of 6 declarations
ZyVersa Therapeutics, Inc. 是一家生物制药公司，专注于开发治疗炎症和代谢疾病的创新疗法。其目标是创建针对潜在疾病机制的疗法。